Cheng-Han Wu
- Oncology top 10%
- HER2/EGFR in Cancer Research 2
- Cancer Research top 10%
-
- Metastasis and carcinoma case studies 2
- Advanced Breast Cancer Therapies 1
- Gastroenterology top 10%
-
- Liver physiology and pathology 2
-
- Human-Automation Interaction and Safety 2
-
- Bioactive Compounds and Antitumor Agents 1
-
- Crop Yield and Soil Fertility 1
-
- Radiopharmaceutical Chemistry and Applications 1
- Co-authors
- Feng PengKathleen I. PritchardFabienne LebrunJosé BaselgaT TaranMartine PiccartHope S. RugoHoward A. Burris
- Partner nations
- TaiwanCanadaUnited States
In The Last Decade
Cheng-Han Wu
15 papers receiving 838 citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Oncology 433
- Cancer Research 233
- Pulmonary and Respiratory Medicine 409
- Gastroenterology 39
- Hepatology 46
Countries citing papers authored by Cheng-Han Wu
This map shows the geographic impact of Cheng-Han Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng-Han Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng-Han Wu more than expected).
Fields of papers citing papers by Cheng-Han Wu
This network shows the impact of papers produced by Cheng-Han Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng-Han Wu. The network helps show where Cheng-Han Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cheng-Han Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 6 | |
| 3 | 2020 | 6 | |
| 4 | 2020 | 10 | |
| 5 | 2018 | 6 | |
| 6 | Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2breakdown → | 2014 | 407 |
| 7 | 2010 | 5 | |
| 8 | 2009 | 10 | |
| 9 | 2006 | 11 | |
| 10 | 2002 | 6 | |
| 11 | Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. | 2000 | 132 |
| 12 | Serum hepatocyte growth factor level associate with gastric cancer progression. | 1999 | 13 |
| 13 | 1998 | 49 | |
| 14 | Serum interleukin-6 levels reflect disease status of gastric cancer. | 1996 | 127 |
| 15 | Morbidity and mortality after radical gastrectomy for patients with carcinoma of the stomach. | 1995 | 69 |
| 16 | Stomach and duodenal alcohol and aldehyde dehydrogenase isozymes in Chinese. | 1991 | 1 |
About Cheng-Han Wu
Cheng-Han Wu is a scholar working on Toxicology, Hepatology and Human-Computer Interaction, having authored 16 papers that have together received 858 indexed citations. Recurring topics across this work include Liver physiology and pathology (2 papers), Metastasis and carcinoma case studies (2 papers), Human-Automation Interaction and Safety (2 papers), HER2/EGFR in Cancer Research (2 papers), Bioactive Compounds and Antitumor Agents (1 paper), Crop Yield and Soil Fertility (1 paper), Advanced Breast Cancer Therapies (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Oncology (433 citations), Cancer Research (233 citations) and Pulmonary and Respiratory Medicine (409 citations). Cheng-Han Wu has collaborated with scholars based in Taiwan, Canada and United States. Frequent co-authors include Feng Peng, Kathleen I. Pritchard, Fabienne Lebrun, José Baselga, T Taran, Martine Piccart, Hope S. Rugo, Howard A. Burris, Michael Gnant and Wing‐Yee Lui. Their work appears in journals such as PLoS ONE, Annals of Oncology and Soil and Tillage Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.